Table 1

Features of four cases of polycythemia vera emerging while in long-term remission from acute myeloid leukemia.

Case reference	Age at AML diagnosis	Sex	AML type	AML treatment	Time to PV from AML diagnosis	JAK2 V617F at AML diagnosis	JAK2 V617F VAF atPV diagnosis
Antonioli et al. [1]	60	M	M2	Flu/AraC/Ida ×1 Ida/Etop ×1 AutoSCT	7 yr	Not detected	28%
Belotti et al. [5]	71	M	M4	AraC/Ida/Etop ×1 Ida/AraC ×2 AraC ×2	7 yr	Not done	Positive
Portell et al. [6]	59	F	M2	Ida/AraC ×1 AraC ×3	5 yr	2%	91%
This case	64	F	M1	AraC/Daun ×8 Flu/AraC/Ida ×2	18 yr	Not detected	17%

Abbreviations: AML, acute myeloid leukemia; AraC, cytarabine; AutoSCT, autologous stem cell transplantation; Daun, daunorubicin; Etop, etoposide; Flu, fludarabine; Ida, idarubicin; M1, acute myeloid leukemia with minimal maturation; M2, acute differentiated myeloid leukemia; M4, acute myelomonocytic leukemia; VAF, variant allele frequency.

Blood Res 2021;56:121~123 https://doi.org/10.5045/br.2021.2021040